Single use infusion pump TJPS series

elastomeric1-wayfor pain management

Product overview

• Directly block the pain at the surgical site
• Reduce the use of opioids
• Improve the comfort of anesthesia and analgesia for patients

Product description
Disposable Postoperative Pain Relief System designed for local continuous analgesia at surgical sites to improve postoperative pain management and reduce systemic opioid use.

Illustration
Disposable Technology (product image provided on page)

Specifications of Disposable Postoperative Pain Relief System
Model | Length of infusion catheter (mm) | Number of Catheter (pcs) | Capacity of Infusion pump (ml) | Flow rate (ml/h)
TJPS040-1-100-2 | 40 | 1 | 100 | 2
TJPS060-1-100-2 | 60 | 1 | 100 | 2
TJPS060-1-250-2 | 60 | 1 | 250 | 2
TJPS060-1-250-5 | 60 | 1 | 250 | 5
TJPS060-2-250-5 | 60 | 2 | 250 | 5
TJPS080-1-100-2 | 80 | 1 | 100 | 2
TJPS080-1-250-2 | 80 | 1 | 250 | 2
TJPS080-1-250-5 | 80 | 1 | 250 | 5
TJPS080-2-250-5 | 80 | 2 | 250 | 5
TJPS100-1-100-2 | 100 | 1 | 100 | 2
TJPS100-1-250-2 | 100 | 1 | 250 | 2
TJPS100-1-250-5 | 100 | 1 | 250 | 5
TJPS100-2-250-5 | 100 | 2 | 250 | 5
TJPS120-1-100-2 | 120 | 1 | 100 | 2
TJPS120-1-250-2 | 120 | 1 | 250 | 2
TJPS120-1-250-5 | 120 | 1 | 250 | 5
TJPS120-2-250-5 | 120 | 2 | 250 | 5
TJPS040-3-250-5 | 40 | 3 | 250 | 5
TJPS060-3-250-5 | 60 | 3 | 250 | 5
TJPS-2-250-5-120x040 | 12040 | 2 | 250 | 5
TJPS-2-250-5-120x060 | 12060 | 2 | 250 | 5
TJPS-2-250-5-100x060 | 10060 | 2 | 250 | 5
TJPS-2-250-5-100x040 | 10040 | 2 | 250 | 5
TJPS-2-220-3.5-120x040 | 12040 | 2 | 220 | 3.5
TJPS-2-220-3.5-120x060 | 12060 | 2 | 220 | 3.5
TJPS-2-220-3.5-060x060 | 6060 | 2 | 220 | 3.5
TJPS-2-220-3.5-080x080 | 8080 | 2 | 220 | 3.5
TJPS-2-220-3.5-100x100 | 100100 | 2 | 220 | 3.5
TJPS-2-220-3.5-120x120 | 120120 | 2 | 220 | 3.5
TJPS-3-250-5-100x100x040 | 10010040 | 3 | 250 | 5
TJPS-3-250-5-100x100x060 | 10010060 | 3 | 250 | 5
TJPS-3-250-5-120x120x060 | 12012060 | 3 | 250 | 5
TJPS-3-250-5-120x120x040 | 12012040 | 3 | 250 | 5

Clinical Trial Reference
This product has been randomly tested in 160 cases in Peking University Hospital and the Third Hospital of Peking University. The test results are summarized below.
Statistics table | Control group (intravenous morphine PCA, number of cases and percentage) | Test group (Continuous local analgesia, lidocaine, number and percentage of cases) | Statistics Volume | P Value | Conclusion
Pain 24 hrs post-surgical - Use of auxiliary analgesics | 10 (12.50) | 14 (17.50) | 0.784a | 0.376a | No significant difference
Pain level (0 N(%)) | 32 (40.00) | 27 (33.75) | 0.741b | 0.459b | No significant difference
Pain level (1 N(%)) | 26 (32.50) | 28 (35.00) | | |
Pain level (2 N(%)) | 21 (26.25) | 25 (31.25) | | |
Pain level (3 N(%)) | 1 (1.25) | 0 (0.00) | | |
Pain 48 hrs post-surgical - Use of auxiliary analgesics | 10 (12.50) | 17 (21.25) | 0.784a | 0.376a | No significant difference
Pain level (0 N(%)) | 36 (45.00) | 36 (45.00) | 0.173b | 0.863b | No significant difference
Pain level (1 N(%)) | 42 (52.50) | 44 (55.00) | | |
Pain level (2 N(%)) | 2 (2.50) | 0 (0.00) | | |
Pain level (3 N(%)) | 0 (0.00) | 0 (0.00) | | |
Patient satisfaction with anesthetic infusion device - Satisfied | 76 (95.00) | 78 (97.50) | | 0.681* | No significant difference
Patient satisfaction - Unsatisfied | 4 (5.00) | 2 (2.50) | | |
Safety analysis - Side effects (urinary retention, nausea and vomiting, etc.) | 7 | 3 | 1.7067 | 0.191 | No significant difference

Caractéristiques / spécifications techniques

• Commercial name: Disposable Postoperative Pain Relief System
• Manufacturer / Brand: LEPU Medical
• Available catheter lengths (reported): 40 mm, 60 mm, 80 mm, 100 mm, 120 mm
• Number of catheters per set: 1, 2 or 3 (depending on model)
• Infusion pump capacities reported: 100 ml and 250 ml (models with 220 ml also listed in table variants)
• Flow rates reported: commonly 2 ml/h and 5 ml/h; other variants include 3 ml/h and 3.5 ml/h
• Multiple model variants provided (see specifications table for full model codes and parameter combinations)
• Clinical evaluation: randomized testing in 160 cases at Peking University Hospital and Third Hospital of Peking University showed no significant differences between test and control groups for the listed endpoints